• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

死亡率与艰难梭菌感染:综述。

Mortality and Clostridium difficile infection: a review.

机构信息

School of Nursing, Midwifery and Paramedicine, Australian Catholic University, Dickson, PO BOX 256, ACT, Australia.

出版信息

Antimicrob Resist Infect Control. 2012 May 30;1(1):20. doi: 10.1186/2047-2994-1-20.

DOI:10.1186/2047-2994-1-20
PMID:22958425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3533881/
Abstract

BACKGROUND

Clostridium difficile infection (CDI) is a common cause of diarrhoea in hospitalised patients. Around the world, the incidence and severity of CDI appears to be increasing, particularly in the northern hemisphere. The purpose of this integrative review was to investigate and describe mortality in hospitalised patients with CDI.

METHODS

A search of the literature between 1 January 2005 and 30 April 2011 focusing on mortality and CDI in hospitalised patients was conducted using electronic databases. Papers were reviewed and analysed individually and themes were combined using integrative methods.

RESULTS

All cause mortality at 30 days varied from 9% to 38%. Three studies report attributable mortality at 30 days, varying from 5.7% to 6.9%. In hospital mortality ranged from 8% to 37.2%

CONCLUSION

All cause 30 day mortality appeared to be high, with 15 studies indicating a mortality of 15% or greater. Findings support the notion that CDI is a serious infection and measures to prevent and control CDI are needed. Future studies investigating the mortality of CDI in settings outside of Europe and North America are needed. Similarly, future studies should include data on patient co-morbidities.

摘要

背景

艰难梭菌感染(CDI)是住院患者腹泻的常见原因。在全球范围内,CDI 的发病率和严重程度似乎都在增加,尤其是在北半球。本次综合回顾的目的是调查和描述 CDI 住院患者的死亡率。

方法

在 2005 年 1 月 1 日至 2011 年 4 月 30 日期间,使用电子数据库对关注住院患者死亡率和 CDI 的文献进行了检索。对论文进行了单独审查和分析,并使用综合方法合并了主题。

结果

30 天全因死亡率从 9%到 38%不等。有三项研究报告了 30 天归因死亡率,从 5.7%到 6.9%不等。住院死亡率从 8%到 37.2%不等。

结论

30 天全因死亡率似乎很高,有 15 项研究表明死亡率为 15%或更高。研究结果支持 CDI 是一种严重感染的观点,需要采取措施预防和控制 CDI。需要在欧洲和北美以外的环境中开展研究 CDI 死亡率的未来研究。同样,未来的研究应该包括患者合并症的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93c2/3533881/ca07e2ff8606/2047-2994-1-20-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93c2/3533881/ca07e2ff8606/2047-2994-1-20-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93c2/3533881/ca07e2ff8606/2047-2994-1-20-1.jpg

相似文献

1
Mortality and Clostridium difficile infection: a review.死亡率与艰难梭菌感染:综述。
Antimicrob Resist Infect Control. 2012 May 30;1(1):20. doi: 10.1186/2047-2994-1-20.
2
Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections.延长住院时间与艰难梭菌感染:对用于检查因医疗保健相关感染而导致的住院时间的方法的综述。
Antimicrob Resist Infect Control. 2012 Apr 20;1(1):14. doi: 10.1186/2047-2994-1-14.
3
A prospective cohort study on hospital mortality due to Clostridium difficile infection.前瞻性队列研究艰难梭菌感染导致的医院死亡率。
Infection. 2012 Oct;40(5):479-84. doi: 10.1007/s15010-012-0258-1. Epub 2012 Apr 17.
4
The evaluation of Clostridium difficile infection (CDI) in a community hospital.社区医院艰难梭菌感染(CDI)的评估。
J Infect Public Health. 2015 Mar-Apr;8(2):155-60. doi: 10.1016/j.jiph.2014.08.002. Epub 2014 Oct 6.
5
Clostridium difficile infection in Thailand.泰国艰难梭菌感染。
Int J Antimicrob Agents. 2015 Jan;45(1):1-7. doi: 10.1016/j.ijantimicag.2014.09.005. Epub 2014 Oct 2.
6
Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.评估中国中部某大学附属医院医院获得性肺炎患者中艰难梭菌感染的风险和疾病负担。
Infection. 2017 Oct;45(5):621-628. doi: 10.1007/s15010-017-1024-1. Epub 2017 May 11.
7
The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.亚洲艰难梭菌感染的出现:发病率及影响的系统评价与荟萃分析
PLoS One. 2017 May 2;12(5):e0176797. doi: 10.1371/journal.pone.0176797. eCollection 2017.
8
The Impact of Clostridium difficile Infection on Mortality in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.艰难梭菌感染对炎症性肠病患者死亡率的影响:系统评价和荟萃分析。
J Clin Gastroenterol. 2019 Feb;53(2):127-133. doi: 10.1097/MCG.0000000000000968.
9
Automated system to identify Clostridium difficile infection among hospitalised patients.用于识别住院患者艰难梭菌感染的自动化系统。
J Hosp Infect. 2009 Aug;72(4):337-41. doi: 10.1016/j.jhin.2009.04.017. Epub 2009 Jul 10.
10
Statin Effects on Incidence, Treatment Success, and Mortality of Clostridium difficile Infections.他汀类药物对艰难梭菌感染的发生率、治疗成功率和死亡率的影响。
J Pharm Pract. 2020 Aug;33(4):497-505. doi: 10.1177/0897190019854956. Epub 2019 Jun 19.

引用本文的文献

1
Comparison of Infection Incidence in a General and a Geriatric Hospital Prior to and During the COVID-19 Pandemic.新冠疫情之前及期间综合医院与老年医院感染发生率的比较
J Clin Med. 2025 Jul 1;14(13):4664. doi: 10.3390/jcm14134664.
2
Comprehensive review of infection: Epidemiology, diagnosis, prevention, and treatment.感染的全面综述:流行病学、诊断、预防与治疗。
World J Gastrointest Pharmacol Ther. 2025 Mar 5;16(1):100560. doi: 10.4292/wjgpt.v16.i1.100560.
3
Guidelines vs mindlines: a qualitative investigation of how clinicians' beliefs influence the application of rapid molecular diagnostics in intensive care.

本文引用的文献

1
Clostridium difficile infection: a new threat on our doorstep.艰难梭菌感染:家门口的新威胁。
Med J Aust. 2011 Apr 4;194(7):331-2. doi: 10.5694/j.1326-5377.2011.tb02998.x.
2
Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008.2002 年至 2008 年间,英国国民保健服务基金会信托中艰难梭菌感染的 30 天死亡率。
J Hosp Infect. 2011 Jan;77(1):11-5. doi: 10.1016/j.jhin.2010.09.017. Epub 2010 Dec 3.
3
Clostridium difficile infection.艰难梭菌感染。
指南与思维定式:关于临床医生的信念如何影响快速分子诊断在重症监护中应用的定性研究
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0115624. doi: 10.1128/aac.01156-24. Epub 2025 Feb 5.
4
Investigating the Effects of Nosocomial Infection Among Acute Leukemia Patients: Insights From the 2020 National Inpatient Sample.探究急性白血病患者医院感染的影响:来自2020年全国住院患者样本的见解
HCA Healthc J Med. 2024 Dec 1;5(6):681-692. doi: 10.36518/2689-0216.1748. eCollection 2024.
5
The global burden and trend of Clostridioides difficile and its association with world antibiotic consumption, 1990-2019.全球艰难梭菌的负担和趋势及其与 1990-2019 年世界抗生素消费的关联。
J Glob Health. 2024 Aug 16;14:04135. doi: 10.7189/jogh.14.04135.
6
Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.波兰弗罗茨瓦夫大学附属医院住院患者艰难梭菌感染死亡率:一项为期 3 年的观察性研究。
BMC Infect Dis. 2024 Jun 23;24(1):625. doi: 10.1186/s12879-024-09495-7.
7
Antimicrobial Resistance and Associated Risk Factors for in Patients Attending Tertiary Care Settings.三级医疗机构患者的抗菌药物耐药性及相关危险因素
J Trop Med. 2024 May 16;2024:6613120. doi: 10.1155/2024/6613120. eCollection 2024.
8
Antimicrobial Effects of Some Natural Products on Adhesion and Biofilm Inhibition of .某些天然产物对……的黏附及生物膜抑制的抗菌作用
Pharmaceutics. 2024 Mar 30;16(4):478. doi: 10.3390/pharmaceutics16040478.
9
Clinical outcomes of clostridioides difficile infection in the very elderly.高龄人群艰难梭菌感染的临床转归。
Intern Emerg Med. 2024 Jun;19(4):1041-1049. doi: 10.1007/s11739-024-03580-0. Epub 2024 Apr 14.
10
Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.基于递进式整群随机试验设计的医院益生菌管理实施策略,以预防医院获得性艰难梭菌感染。
BMC Health Serv Res. 2023 Dec 11;23(1):1386. doi: 10.1186/s12913-023-10350-9.
Am J Med Sci. 2010 Sep;340(3):247-52. doi: 10.1097/MAJ.0b013e3181e939d8.
4
The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.艰难梭菌感染在住院和门诊环境中的发病率和严重程度不断增加。
Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):409-16. doi: 10.1586/egh.10.48.
5
The emergence of 'hypervirulence' in Clostridium difficile.艰难梭菌“超级毒力”的出现。
Int J Med Microbiol. 2010 Aug;300(6):387-95. doi: 10.1016/j.ijmm.2010.04.008. Epub 2010 May 23.
6
Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.台湾南部某医学中心艰难梭菌感染:发生率、临床特征和预后。
J Microbiol Immunol Infect. 2010 Apr;43(2):119-25. doi: 10.1016/S1684-1182(10)60019-9.
7
Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.艰难梭菌感染后死亡的预测因素:来自英国一所教学医院的 128 株定型病例报告。
Clin Infect Dis. 2010 Jun 15;50(12):e77-81. doi: 10.1086/653012.
8
A review of mortality due to Clostridium difficile infection.艰难梭菌感染导致死亡率的研究综述。
J Infect. 2010 Jul;61(1):1-8. doi: 10.1016/j.jinf.2010.03.025. Epub 2010 Mar 31.
9
Clinical predictors and risk factors for relapsing Clostridium difficile infection.复发性艰难梭菌感染的临床预测指标和危险因素。
Am J Med Sci. 2010 Apr;339(4):350-5. doi: 10.1097/MAJ.0b013e3181d3cdaa.
10
Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany.德国黑森州的艰难梭菌 001、017 和 027 型与致死性艰难梭菌感染相关。
Euro Surveill. 2009 Nov 12;14(45):19403. doi: 10.2807/ese.14.45.19403-en.